Siemens and Invivo Partner to Offer Computer-Aided-Detection System For MRI; DynaCAD to be Integrated with MAGNETOM MRI Systems

Business Wire, Nov 3, 2005

MALVERN, Pa. & PEWAUKEE, Wis. -- Siemens Medical Solutions (NYSE:SI) and Invivo Corporation, a subsidiary of Intermagnetics General Corporation (Nasdaq:IMGC) today announced a strategic partnership that will integrate Invivo's computer-aided-detection (CAD) system with Siemens' MAGNETOM magnetic resonance imaging (MRI) systems for advanced breast MRI technology. DynaCAD(TM) will provide radiologists with more detailed information for breast MRI exams to assist doctors in detecting disease earlier and streamline workflow by managing the large volume of images involved in today's studies.

"Breast cancer is the most common malignancy among women in the United States and is second only to lung cancer in all cancer-related deaths," said Nancy Gillen, vice president, MRI Division, Siemens Medical Solutions. "It is essential to identify and administer treatment at an early stage. The combination of Siemens' MRI technologies and Invivo's CAD system will supply doctors with a powerful tool that enables them to diagnose breast disease in patients earlier."

With an estimated 211,240 new breast cancer cases expected to occur and a prediction of 40,410 related deaths in the U.S. in 2005(1), the need for earlier detection is evident. DynaCAD is an advanced CAD system for analyzing magnetic resonance images, providing physicians with a number of new tools for improving their diagnostic confidence, workflow and throughput.

The system consists of five functional modules:

--DynaMATCH(TM) - Selectable 2D/3D image registration for suppression of image motion artifacts and automatic image subtraction

--DynaMAP(TM) - Functional color parameter maps to visualize changes in MRI signal intensity

--DynaMIP(TM) - Dynamic maximum intensity projections for interactive functional 3D visualization

--DynaFLOW(TM) - Interactive access to time-intensity curve data

--DynaLOC(TM) - Automatic calculation of target coordinates for MRI-guided interventions for improved speed and accuracy

"We look forward to expanding our collaborative efforts with Siemens by providing their MAGNETOM customers with the best possible solutions for MRI mammography," said Thomas Tynes, director, Interventional MRI Business Group, Invivo Corporation. "The addition of DynaCAD to the existing line of Siemens-certified Invivo breast MRI coils and biopsy systems provides a comprehensive, fully-integrated approach to breast MRI diagnostics and intervention."

The integrated solution of DynaCAD and Siemens' MRI systems will be distributed by Siemens on a worldwide basis for MAGNETOM MRI users and includes the MAGNETOM Trio(TM), MAGNETOM Espree(TM), MAGNETOM Avanto(TM) and MAGNETOM Symphony(TM). Invivo currently provides a wide variety of Siemens-certified products for the MRI mammography market, and the introduction of DynaCAD further expands this partnership by providing a complete solution approach to MRI breast care.

Siemens Medical Solutions of Siemens AG (NYSE:SI) with headquarters in Malvern, Pennsylvania and Erlangen, Germany, is one of the largest suppliers to the healthcare industry in the world. The company is known for bringing together innovative medical technologies, healthcare information systems, management consulting, and support services, to help customers achieve tangible, sustainable, clinical and financial outcomes. Employing approximately 31,000 people worldwide and operating in more than 120 countries, Siemens Medical Solutions reported sales of 7.07 billion EUR, orders of 8.12 billion EUR and group profit of 1.05 billion EUR for fiscal 2004. More information can be obtained by visiting http://www.usa.siemens.com/medical-pressroom.> Invivo Corporation is a wholly-owned subsidiary of Intermagnetics General Corporation (NASDAQ:IMGC). Intermagnetics (www.intermagnetics.com) draws on the financial strength, operational excellence and technical leadership in the market of Magnetic Resonance Imaging (MRI) as well as its expanding businesses within Medical Devices that encompass Invivo Diagnostic Imaging (focusing on MRI components & imaging sub-systems) and Invivo Patient Care (focusing on monitoring & other patient care devices). Intermagnetics is also a prominent participant in superconducting applications for Energy Technology. The company has a more than 30-year history as a successful developer, manufacturer and marketer of superconducting materials, high-field magnets, medical systems & components and other specialized high-value added devices.

(1)Cancer Facts and Figures 2005, American Cancer Society

PHOTOGRAPHY AVAILABLE UPON REQUEST